I have posted about this kind of stuff before. There are a few drugs (and supplememnts) that have been shown to upregulate ABCD2/3 and, indeed, to lower VLCFA levels.
Of course, lowering in the right places is the holy grail.
I mentioned Valproic Acid to my neurologist a few years back. He prescribed it without thinking too hard.
400 mg per day.
I took it, didn't get better, gave up.
I started again earlier this year, same dose, then I started to Google the scientific studies.
academic.oup.com/hmg/articl...
This is a long report, dealing primarily with mice, but it does mention a limited human trial.
"Five patients with X-ALD were enrolled after assessing normal liver transaminase activities. Four of the patients were affected with demyelinating cerebral adrenoleukodystrophy at ages between 7 and 18 years old. The fifth patient was affected with pure AMN and Addison's disease. Laboratory testing, including a basic chemistry profile, complete blood count with platelets, transaminases, carnitine profile, amylase, lipase and trough VPA levels, was performed at baseline and every 4 weeks following initiation. Dosing of VPA (Depakine), calculated at 40 mg/kg/day, was typical of that used in epilepsy patients (15–50 mg/kg/day). Patients reported no side effects related to VPA administration and compliance with the treatment was checked by monitoring the serum concentrations of VPA"
Here is the result:
"A 6-month pilot trial of VPA in X-ALD patients resulted in reversion of the oxidative damage of proteins in peripheral blood mononuclear cells. Thus, we propose VPA as a promising novel therapeutic approach that warrants further clinical investigation in X-ALD."
I'll buy that
40mg/kg/day.
At my 60kg, that equates to 2400mg per day.
My neurologist wouldn't go that high, but he upped my dose to 1200mg. So, I am half-way there.